CEMPRA PHARMACEUTICALS, INC.
|CEMPRA PHARMACEUTICALS, INC. Patent applications|
|Patent application number||Title||Published|
|20130066056||PROCESS FOR PREPARING TRIAZOLE-CONTAINING KETOLIDE ANTIBIOTICS - The invention described herein pertains to processes for the preparation of macrolide antibacterial agents. In particular, the invention pertains to processes for preparing macrolides and ketolides from erythromycin A.||03-14-2013|
|20130045937||PARENTERAL FORMULATIONS OF MACROLIDE ANTIBIOTICS - Described herein are pharmaceutical compositions adapted for the parenteral administration of macrolide antibiotics, such as triazole-containing and fluoroketolide antibiotics. Also described herein are methods for their use in the treatment of bacterial, protozoal, and other infections.||02-21-2013|
|20130018008||CRYSTALLINE FORMS OF A MACROLIDE, AND USES THEREFOR - New crystalline forms of macrolide compounds, and pharmaceutical compositions thereof, are described herein. In addition, processes for preparing the crystalline forms are described herein.||01-17-2013|
|20120172323||METHODS FOR TREATING MALARIA, TUBERCULOSIS AND MAC DISEASES - Described herein are formulations and methods for treating diseases caused by infectious pathogens, including||07-05-2012|
|20110301132||METHODS OF TREATING URETHRITIS AND RELATED INFECTIONS USING FUSIDIC ACID - Methods for the treatment and prevention of a bacterial infection caused by||12-08-2011|
|20110237534||METHODS FOR TREATING GASTROINTESTINAL DISEASES - Described herein are macrolide and ketolide antibiotics and pharmaceutical compositions, methods, and uses thereof for treating gastrointestinal diseases.||09-29-2011|
|20110201566||METHODS FOR TREATING RESISTANT DISEASES USING TRIAZOLE CONTAINING MACROLIDES - Triazole-containing macrolide and ketolide antibiotics, therapeutic compositions containing them and methods of use for treating diseases caused by one or more resistant organisms are described.||08-18-2011|
|20110195920||BIODEFENSES USING TRIAZOLE-CONTAINING MACROLIDES - Use of macrolide and ketolide antibiotics for the treatment of acute exposure and diseases caused by biodefense pathogens is described.||08-11-2011|
|20100216731||PROCESS FOR THE PREPARATION OF MACROLIDE ANTIBACTERIAL AGENTS - Described herein are processes for the preparation of compounds of formula (I): and pharmaceutically acceptable salts, solvates, and hydrates thereof.||08-26-2010|
Patent applications by CEMPRA PHARMACEUTICALS, INC.